Diagnosing and treating depression in the elderly

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL.,24, 2001, Pages 18-22

  Nelson, J C ^a  

^a YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; AGING; ARTICLE; BEREAVEMENT; COMORBIDITY; DEMENTIA; DEPRESSION; HUMAN; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QUALITY OF LIFE;

AGE FACTORS; AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COGNITION; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 0034793727     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Diagnosis and treatment of depression in late life
2. Treatment of major depression in the elderly
3. Dementia and bereavement: Adverse life experiences complicating depression in later life. Primary Care Companion
4. Diagnosis and treatment of depression in late life
5. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients
6. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease
7. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life
8. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression
9. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data
10. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia
11. Sertraline in the treatment of elderly depression: Results of a large, multicenter, placebo-controlled trial
12. Paroxetine in the treatment of depression in elderly patients
13. Drug interactions
14. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports
15. Fluoxetine in elderly patients: Is there cause for concern?
16. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study
17. A double-blind comparison of sertraline and fluoxetine in depressed elderly patients
18. Antidepressants and the risk of falls among nursing home residents
19. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients
20. Comparative effects of sertraline and nortriptyline on body sway in older depressed patients
21. Long-term effects of antidepressants on balance, equilibrium, and postural reflexes
22. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly
23. An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients
24. Nefazodone versus maprotiline in elderly depressed patients
25. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients
26. Is venlafaxine more effective than the SSRIs? Mage- and meta-analyses of 17 controlled studies
27. Effects of venlafaxine on blood pressure: A meta-analysis of original data from 3744 depressed patients
28. The additional benefit of extending an anti-depressant trial past seven weeks in the depressed elderly